VEGFA and renal cell carcinoma: As recently shown, there are some single nucleotide polymorphisms (SNPs) (e.g., in genes involved in the VEGF pathway) that are associated with the risk of RCC (69, 70) as well as with RR and adverse events in patients receiving TTs.